Combination of APC resistance and acquired protein S deficiency in a haemodialysis patient with recurrent A-V shunt thrombosis

Nephrology Dialysis Transplantation

Volumn 14, Issue 10, 1999, Pages 2474-2477

  Mitsiev, Ivaylo ^a   Reinhold, Simone ^a   Ziemer, Sabine ^a   Neumayer, Hans H ^a   Hocher, Berthold ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anticoagulation; APC resistance; Protein S deficiency; Renal failure; Shunt thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; HEPARIN; PHENPROCOUMON; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTERIOVENOUS SHUNT; ARTICLE; CASE REPORT; FEMALE; GENE MUTATION; GENOTYPE; GLOMERULONEPHRITIS; HEMODIALYSIS PATIENT; HETEROZYGOSITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; THROMBOSIS;

ADULT; ARTERIOVENOUS SHUNT, SURGICAL; DRUG RESISTANCE; FEMALE; HUMANS; PROTEIN C; PROTEIN S DEFICIENCY; RENAL DIALYSIS; THROMBOSIS;

EID: 0032873184     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.10.2474     Document Type: Article

References (40)

1. Fodinger M, Mannhalter C, Pabinger I et al. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients. Nephrol Dial Transplant 1996; 11: 668-672
2. Perez-Mijares R, Payan-Lopez J, Guzman-Zamudio JL et al. Free protein S deficiency in hemodialysis patients due to vascular calcifications? Nephron 1996; 74: 356-360
3. Heeb MJ, Koijima Y, Greengard JS, Griffin JH. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V. Blood 1995; 85: 3405-3411
4. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc. Natl Acad. Sci USA 1993; 90: 1004-1008
5. Bertina RM, Koeleman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
6. Svensson PJ, Dahlbaeck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
7. Fisher M, Fernandez JA, Ameriso SF et al. Activated protein C resistance in ischemic stroke not due to factor V arginine506→glutamine mutation. Stroke 1996; 27: 1163-1166
8. Bernardi F, Faioni EM, Castoldi E et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997; 90: 1552-1557
9. Williamson D, Brown K, Luddington R, Baglin C, Baglin T. Factor V Cambridge: a new mutation (Arg306→Thr) associated with resistance to activated protein C. Blood 1998; 91: 1140-1144
10. Zoller B, Hillarp A, Berntorp E, Dahlback B. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis. Annu Rev Med 1997; 48: 45-58
11. Kodaira H, Ishida F, Shimodaira S, Takamiya O, Furihata K, Kitano K. Resistance to activated protein C and Arg506 Gln factor V mutation are uncommon in eastern Asian populations. Acta Haematol 1997; 98: 22-25
12. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
13. Svensson PJ, Zoller B, Mattiasson I, Dahlback B. The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis. J Intern Med 1997; 241: 379-385
14. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457
15. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for Factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-1508
16. Simioni P, Scudeller A, Radossi P et al. 'Pseudo homozygous' activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Thromb Haemostasis 1996; 75: 422-426
17. Weih M, Vetter B, Ziemer S et al. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis. J Neurol 1998; 245: 149-152
18. Bontempo FA, Hassett AC, Faruki H, Steed DL, Webster MW, Makaroun MS. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation. J Vasc Surg 1997; 2: 271-275
19. Demarmels-Biasiutti F, Merlo C, Furlan M, Sulzer I, Binder BR, Lammle B. No association of APC resistance with myocardial infarction. Blood Coagul Fibrinolysis 1995; 6: 456-459
20. Dahlback B, Stenflo J. High molecular weight complex in human plasma between vitamin K dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci USA 1981; 78: 2512-2516
21. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-2088
22. Mannucci PM, Valsecchi C, Krachmalnicoff A, Faioni EM, Tripodi A. Familial dysfunction of protein S. Thromb Haemostasis 1989; 62: 763-766
23. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism - results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemostasis 1997; 77: 444-451
24. Lambermont B, Ghuysen A, Marcelle R, Pierard L. Cerebrovascular accident and aortic thrombosis in a patient with protein S deficiency. Arch Mal Coeur Vaiss 1997; 90: 99-102
25. Beattie S, Norton M, Doll D. Coronary thrombosis associated with inherited protein S deficiency: a case report. Heart Lung 1997; 26: 76-79
26. Caceres-Sansaloni A, Romero-Barbero JL, Hernandez-Nunez A. Coagulation-inhibiting proteins; implications for cerebrovascular disorders. Rev Clin Esp 1996; 196: 737-740
27. Albitar S, Genin R, Serveaux MO, Jacquesson M, Jean-Louis P. Renal vein thrombosis and constitutional protein S deficiency. Rev Med Intern 1996; 17: 746-748
28. Faioni EM, Valsecchi C, Palla A, Taioli E, Razzari C, Mannucci PM. Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemostasis 1997; 78: 1343-1346
29. Zoller B, Berntsdotter A, Garcia de Frutos P, Dahlback B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-3523
30. Winkler UH, Zierleyn JP, Schulte H, Collet W, Schindler AE. Routine screening for coagulation inhibitors prior to prescribing the pill: prevalence data from a large cohort of German pill starters. Eur J Contracept Reprod Health Care 1996; 1: 47-52
31. Simioni P, Prandoni P, Girolami A. Patients with AT III, protein C or protein S defects show no associated hereditary APC-resistance (letter). Thromb Haemostasis 1994; 72: 481-482
32. Koeleman BP, van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemostasis 1995; 74: 580-583
33. Cooper PC, Hampton KK, Makris M, Abuzenadah A, Paul B, Preston FE. Further evidence that activated protein C resistance can be misdiagnosed as inherited functional protein S deficiency. Br J Haematol 1994; 88: 201-203
34. Zoeller B, He X, Dahlbaeck B. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease. Thromb Haemostasis 1995; 73: 743-745
35. Lewandowski K, Turowiecka Z, Zawilska K. Thrombophilia in a family with resistance to activated protein C and protein S deficiency. Pol Arch Med Wewn 1995; 94: 518-524
36. Biasiutti FD, Stucki B, Solenthaler M, Tobler A, Furlan M, Laemmle B. Venous thrombosis after caesarean section in a young woman with homozygous APC resistance and type I protein S deficiency (letter). Eur J Hematol 1997; 58: 127-129
37. Neri S, Ierna D, Sfogliano L. Deficit of anticoagulant factors, endothelial stress and thrombophilia. Min Cardioangiol 1997; 45: 503-507
38. Fischereder M, Gohring P, Schneeberger H et ai. Early loss of renal transplants in patients with thrombophilia. Transplantation 1998; 65: 936-939
39. Blanshard C, Pasi J, Rolles K, Davidson B, Jain S, Burroughs A. Acute Budd-Chiari syndrome treated by liver transplantation in a woman homozygous for factor V Leiden. Eur J Gastroenterol Hepatol 1996; 8: 925-927
40. Foster PA, Varma RR. Phenotypic correction of activated protein C resistance following orthotopic liver transplantation. Blood Coagul Fibrinolysis 1996; 7: 65-68